Proteomic Analysis of Pancreatic Cancer and MBD1 Knock-Down
Author Information
Author(s): Liu Chen, Chen Yaohui, Yu Xianjun, Jin Chen, Xu Jin, Long Jiang, Ni Quanxing, Fu Deliang, Jin Hong, Bai Chen
Primary Institution: Pancreatic Disease Institute, Department of General Surgery, Huashan Hospital, Fudan University
Hypothesis
MBD1 knock-down in pancreatic cancer cells will lead to differential protein expression that may provide insights into its role in tumorigenesis.
Conclusion
The study suggests that differential proteins identified may be associated with MBD1's function in pancreatic cancer development.
Supporting Evidence
- Five proteins were found to be up-regulated and nine down-regulated after MBD1 knock-down.
- Proteins identified are involved in tumorigenesis and some are prognostic biomarkers for human malignant tumors.
- Quantitative RT-PCR confirmed that MBD1 was downregulated about 14.76-fold in the knock-down cells.
Takeaway
Researchers looked at how silencing a protein called MBD1 in pancreatic cancer cells changed the levels of other proteins, which might help us understand how pancreatic cancer develops.
Methodology
The study used stable RNA interference to knock down MBD1 in pancreatic cancer cells and analyzed protein expression changes using two-dimensional gel electrophoresis and mass spectrometry.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website